InsiderClue
← All stocks

MADRIGAL PHARMACEUTICALS, INC.

MDGL Net selling
CIK 0001157601 #854 in the set updated 17 Sep 2026
Bought (120 mo)
$141.04M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$792.30M
$17.40M on a plan · $291.32M straight out of an exercise
Sold at will
$483.58M
56 of 544 sales
Net
−$651.26M
−$342.54M against sales at will

By person

23 insiders · 766 transactions
117×

Bill Sibold holds 117 times base salary in stock. $108.04M of shares against $918.53K in salary for 2025.

Salary from the company's own proxy. The shares are what Bill Sibold last reported holding, valued at $546.38, the price Common Stock was last bought or sold at on the open market here, on 11 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
CRAVES FRED B
Director
$249.39K (3)
$222.54M (34)
−$222.29M
361,076
1.56%
$197.28M
−94.3%
BAY CITY CAPITAL LLC entity
10% owner
—
$210.34M (7)
−$210.34M
1,261
0.0055%
$688.98K
−100.0%
FRIEDMAN PAUL A
Director
$967.52K (2)
$147.39M (105) scheduled
−$146.42M
842,704
3.65%
$460.43M
−4.5%
BAKER BROS. ADVISORS LP entity
Director
$139.67M (192)
—
+$139.67M
1,948,876
8.44%
$1.06B
+45.3%
Taub Rebecca
Director
—
$89.31M (92) scheduled
−$89.31M
1,108,207
4.80%
$605.50M
+9.0%
BATE KENNETH
Director
—
$27.02M (43) scheduled
−$27.02M
2,627
0.0114%
$1.44M
—
Levy Richard S
Director
$145.80K (20)
$20.04M (47) scheduled
−$19.89M
22,469
0.0973%
$12.28M
—
Sibold William John
President and CEO
—
$18.86M (42)
−$18.86M
197,746
0.8559%
$108.04M
—
Daly James M
Director
—
$13.59M (19) scheduled
−$13.59M
3,081
0.0133%
$1.68M
—
Waltermire Robert E.
Senior VP, Chief Pharma Dev.
—
$11.25M (30) scheduled
−$11.25M
5,789
0.0251%
$3.16M
—
Sukhija Remy
Chief Commercial Officer
—
$8.22M (18) scheduled
−$8.22M
15,001
0.0649%
$8.20M
—
Lynch Brian Joseph
SVP and General Counsel
—
$7.63M (32) scheduled
−$7.63M
17,691
0.0766%
$9.67M
—
Dier Mardi
EVP and CFO
—
$4.49M (31) scheduled
−$4.49M
12,490
0.0541%
$6.82M
+40.7%
MILLIGAN DAVID V
Director
—
$3.57M (2)
−$3.57M
0
0.0000%
$0.00
—
Schneebaum Marc R
Chief Financial Officer
—
$2.90M (1) scheduled
−$2.90M
41,668
0.1803%
$22.77M
−4.9%
Huntsman Carole
Chief Commercial Officer
—
$2.65M (25) scheduled
−$2.65M
12,692
0.0549%
$6.93M
—
Kelley Shannon T
General Counsel
—
$1.54M (14) scheduled
−$1.54M
11,474
0.0497%
$6.27M
+314.7%
Soergel David
Chief Medical Officer
—
$951.98K (2) scheduled
−$951.98K
10,033
0.0434%
$5.48M
—
Howarth Alex G.
Chief Financial Officer
—
—
—
18,737
0.0811%
$10.24M
—
Thakkar Rita
Chief Accounting Officer
—
—
—
2,398
0.0104%
$1.31M
—
FOUSE JACQUALYN A
Director
—
—
—
1,551
0.0067%
$847.43K
—
Brennan Daniel J.
Director
—
—
—
1,371
0.0059%
$749.08K
—
REED JOHN C
Director
—
—
—
647
0.0028%
$353.51K
—

Individual transactions

117
Insider
Date
Role
Action
Shares
Price
Amount
Taub Rebecca
9 Jan 2026
Director
Sold after exercise
400
$542.72
$217.09K
Taub Rebecca
9 Jan 2026
Director
Sold after exercise
40
$540.26
$21.61K
Taub Rebecca
9 Jan 2026
Director
Sold after exercise
400
$539.26
$215.71K
Taub Rebecca
9 Jan 2026
Director
Sold after exercise
40
$537.84
$21.51K
Taub Rebecca
9 Jan 2026
Director
Sold after exercise
385
$536.88
$206.70K
Taub Rebecca
9 Jan 2026
Director
Sold after exercise
299
$535.80
$160.21K
Taub Rebecca
9 Jan 2026
Director
Sold after exercise
89
$534.93
$47.61K
Taub Rebecca
9 Jan 2026
Director
Sold after exercise
271
$534.18
$144.76K
Taub Rebecca
9 Jan 2026
Director
Sold after exercise
40
$532.50
$21.30K
Taub Rebecca
9 Jan 2026
Director
Sold after exercise
30
$531.05
$15.93K
Taub Rebecca
9 Jan 2026
Director
Sold after exercise
256
$530.45
$135.80K
Taub Rebecca
9 Jan 2026
Director
Sold after exercise
554
$529.28
$293.22K
Taub Rebecca
9 Jan 2026
Director
Sold after exercise
465
$528.16
$245.59K
Taub Rebecca
9 Jan 2026
Director
Sold after exercise
1,135
$526.95
$598.09K
Taub Rebecca
9 Jan 2026
Director
Sold after exercise
913
$526.05
$480.28K
Taub Rebecca
9 Jan 2026
Director
Sold after exercise
1,489
$525.12
$781.90K
Taub Rebecca
9 Jan 2026
Director
Sold after exercise
1,335
$524.06
$699.62K
Taub Rebecca
9 Jan 2026
Director
Sold after exercise
732
$522.98
$382.82K
Taub Rebecca
9 Jan 2026
Director
Sold after exercise
588
$521.95
$306.91K
Taub Rebecca
9 Jan 2026
Director
Sold after exercise
440
$521.11
$229.29K
Taub Rebecca
9 Jan 2026
Director
Sold after exercise
539
$519.89
$280.22K
Taub Rebecca
9 Jan 2026
Director
Sold after exercise
970
$518.67
$503.11K
Taub Rebecca
9 Jan 2026
Director
Sold after exercise
2,044
$517.84
$1.06M
Taub Rebecca
9 Jan 2026
Director
Sold after exercise
521
$516.81
$269.26K
Taub Rebecca
9 Jan 2026
Director
Sold after exercise
1,578
$515.82
$813.97K
Taub Rebecca
9 Jan 2026
Director
Sold after exercise
937
$514.63
$482.21K
Taub Rebecca
9 Jan 2026
Director
Sold after exercise
960
$513.12
$492.59K
Taub Rebecca
9 Jan 2026
Director
Sold after exercise
960
$512.02
$491.54K
Taub Rebecca
9 Jan 2026
Director
Sold after exercise
200
$551.24
$110.25K
Taub Rebecca
9 Jan 2026
Director
Sold after exercise
40
$545.79
$21.83K
FRIEDMAN PAUL A
9 Jan 2026
Director
Sold after exercise
40
$545.79
$21.83K
FRIEDMAN PAUL A
9 Jan 2026
Director
Sold after exercise
600
$540.36
$324.21K
FRIEDMAN PAUL A
9 Jan 2026
Director
Sold after exercise
480
$539.23
$258.83K
FRIEDMAN PAUL A
9 Jan 2026
Director
Sold after exercise
80
$537.85
$43.03K
FRIEDMAN PAUL A
9 Jan 2026
Director
Sold after exercise
487
$536.88
$261.46K
FRIEDMAN PAUL A
9 Jan 2026
Director
Sold after exercise
473
$536.02
$253.54K
FRIEDMAN PAUL A
9 Jan 2026
Director
Sold after exercise
148
$535.29
$79.22K
FRIEDMAN PAUL A
9 Jan 2026
Director
Sold after exercise
332
$534.16
$177.34K
FRIEDMAN PAUL A
9 Jan 2026
Director
Sold after exercise
80
$532.50
$42.60K
FRIEDMAN PAUL A
9 Jan 2026
Director
Sold after exercise
280
$530.69
$148.59K
FRIEDMAN PAUL A
9 Jan 2026
Director
Sold after exercise
166
$529.76
$87.94K
FRIEDMAN PAUL A
9 Jan 2026
Director
Sold after exercise
691
$529.17
$365.65K
FRIEDMAN PAUL A
9 Jan 2026
Director
Sold after exercise
575
$528.18
$303.70K
FRIEDMAN PAUL A
9 Jan 2026
Director
Sold after exercise
1,560
$526.97
$822.07K
FRIEDMAN PAUL A
9 Jan 2026
Director
Sold after exercise
1,066
$526.00
$560.72K
FRIEDMAN PAUL A
9 Jan 2026
Director
Sold after exercise
2,432
$525.05
$1.28M
FRIEDMAN PAUL A
9 Jan 2026
Director
Sold after exercise
1,199
$524.10
$628.39K
FRIEDMAN PAUL A
9 Jan 2026
Director
Sold after exercise
970
$523.00
$507.31K
FRIEDMAN PAUL A
9 Jan 2026
Director
Sold after exercise
840
$521.98
$438.46K
FRIEDMAN PAUL A
9 Jan 2026
Director
Sold after exercise
681
$521.03
$354.82K
FRIEDMAN PAUL A
9 Jan 2026
Director
Sold after exercise
846
$519.88
$439.82K
FRIEDMAN PAUL A
9 Jan 2026
Director
Sold after exercise
1,363
$518.68
$706.97K
FRIEDMAN PAUL A
9 Jan 2026
Director
Sold after exercise
2,450
$517.86
$1.27M
FRIEDMAN PAUL A
9 Jan 2026
Director
Sold after exercise
766
$516.84
$395.90K
FRIEDMAN PAUL A
9 Jan 2026
Director
Sold after exercise
1,996
$515.81
$1.03M
FRIEDMAN PAUL A
9 Jan 2026
Director
Sold after exercise
1,345
$514.68
$692.25K
FRIEDMAN PAUL A
9 Jan 2026
Director
Sold after exercise
1,094
$513.11
$561.34K
FRIEDMAN PAUL A
9 Jan 2026
Director
Sold after exercise
1,480
$511.98
$757.73K
FRIEDMAN PAUL A
9 Jan 2026
Director
Sold after exercise
280
$551.24
$154.35K
Taub Rebecca
10 Dec 2025
Director
Sold after exercise
200
$555.39
$111.08K
Taub Rebecca
10 Dec 2025
Director
Sold after exercise
1,027
$554.84
$569.82K
Taub Rebecca
10 Dec 2025
Director
Sold after exercise
3,087
$553.88
$1.71M
Taub Rebecca
10 Dec 2025
Director
Sold after exercise
3,857
$552.81
$2.13M
Taub Rebecca
10 Dec 2025
Director
Sold after exercise
4,410
$551.85
$2.43M
Taub Rebecca
10 Dec 2025
Director
Sold after exercise
4,723
$550.99
$2.60M
Taub Rebecca
10 Dec 2025
Director
Sold after exercise
486
$550.07
$267.33K
Taub Rebecca
10 Dec 2025
Director
Sold after exercise
369
$548.56
$202.42K
Taub Rebecca
10 Dec 2025
Director
Sold after exercise
491
$547.76
$268.95K
FRIEDMAN PAUL A
10 Dec 2025
Director
Sold after exercise
160
$555.39
$88.86K
FRIEDMAN PAUL A
10 Dec 2025
Director
Sold after exercise
1,029
$555.00
$571.09K
FRIEDMAN PAUL A
10 Dec 2025
Director
Sold after exercise
5,001
$553.83
$2.77M
FRIEDMAN PAUL A
10 Dec 2025
Director
Sold after exercise
5,533
$552.74
$3.06M
FRIEDMAN PAUL A
10 Dec 2025
Director
Sold after exercise
7,193
$551.67
$3.97M
FRIEDMAN PAUL A
10 Dec 2025
Director
Sold after exercise
4,316
$550.93
$2.38M
FRIEDMAN PAUL A
10 Dec 2025
Director
Sold after exercise
409
$549.99
$224.94K
FRIEDMAN PAUL A
10 Dec 2025
Director
Sold after exercise
535
$548.51
$293.45K
FRIEDMAN PAUL A
10 Dec 2025
Director
Sold after exercise
624
$547.75
$341.79K
Dier Mardi
2 Dec 2025
EVP and CFO
Sold after exercise
80
$596.19
$47.69K
Dier Mardi
2 Dec 2025
EVP and CFO
Sold after exercise
74
$595.20
$44.05K
Dier Mardi
2 Dec 2025
EVP and CFO
Sold after exercise
160
$590.37
$94.46K
Dier Mardi
2 Dec 2025
EVP and CFO
Sold after exercise
160
$589.65
$94.34K
Dier Mardi
2 Dec 2025
EVP and CFO
Sold after exercise
240
$587.85
$141.08K
Dier Mardi
2 Dec 2025
EVP and CFO
Sold after exercise
240
$585.44
$140.51K
Dier Mardi
2 Dec 2025
EVP and CFO
Sold after exercise
480
$579.85
$278.33K
Dier Mardi
2 Dec 2025
EVP and CFO
Sold after exercise
258
$578.83
$149.34K
Dier Mardi
2 Dec 2025
EVP and CFO
Sold after exercise
320
$577.81
$184.90K
Dier Mardi
2 Dec 2025
EVP and CFO
Sold after exercise
240
$576.15
$138.28K
Dier Mardi
2 Dec 2025
EVP and CFO
Sold after exercise
120
$574.95
$68.99K
Dier Mardi
2 Dec 2025
EVP and CFO
Sold after exercise
717
$574.00
$411.56K
Dier Mardi
2 Dec 2025
EVP and CFO
Sold after exercise
354
$573.02
$202.85K
Dier Mardi
2 Dec 2025
EVP and CFO
Sold after exercise
410
$571.99
$234.52K
Dier Mardi
2 Dec 2025
EVP and CFO
Sold after exercise
320
$570.39
$182.52K
Levy Richard S
13 Nov 2025
Director
Sold after exercise
40
$530.21
$21.21K
Levy Richard S
13 Nov 2025
Director
Sold after exercise
440
$528.60
$232.59K
Levy Richard S
13 Nov 2025
Director
Sold after exercise
200
$527.85
$105.57K
Levy Richard S
13 Nov 2025
Director
Sold after exercise
120
$526.68
$63.20K
Levy Richard S
13 Nov 2025
Director
Sold after exercise
153
$524.49
$80.25K
Levy Richard S
13 Nov 2025
Director
Sold after exercise
811
$523.66
$424.69K
Levy Richard S
13 Nov 2025
Director
Sold after exercise
1,434
$522.70
$749.56K
Levy Richard S
13 Nov 2025
Director
Sold after exercise
1,094
$521.79
$570.84K
Levy Richard S
13 Nov 2025
Director
Sold after exercise
308
$520.68
$160.37K
Levy Richard S
13 Nov 2025
Director
Sold after exercise
1,355
$519.67
$704.15K
Levy Richard S
13 Nov 2025
Director
Sold after exercise
835
$518.53
$432.97K
Levy Richard S
13 Nov 2025
Director
Sold after exercise
645
$517.51
$333.80K
Levy Richard S
13 Nov 2025
Director
Sold after exercise
919
$515.64
$473.88K
Levy Richard S
13 Nov 2025
Director
Sold after exercise
146
$514.67
$75.14K
BATE KENNETH
5 Nov 2025
Director
Sold after exercise
30
$490.98
$14.73K
BATE KENNETH
5 Nov 2025
Director
Sold after exercise
933
$489.95
$457.12K
BATE KENNETH
5 Nov 2025
Director
Sold after exercise
696
$489.09
$340.41K
BATE KENNETH
5 Nov 2025
Director
Sold after exercise
2,775
$487.49
$1.35M
BATE KENNETH
5 Nov 2025
Director
Sold after exercise
827
$486.73
$402.53K
BATE KENNETH
5 Nov 2025
Director
Sold after exercise
1,008
$485.54
$489.42K
BATE KENNETH
5 Nov 2025
Director
Sold after exercise
1,931
$484.78
$936.10K
BATE KENNETH
5 Nov 2025
Director
Sold after exercise
2,069
$483.41
$1.00M
BATE KENNETH
5 Nov 2025
Director
Sold after exercise
1,284
$482.41
$619.42K
BATE KENNETH
5 Nov 2025
Director
Sold after exercise
3,259
$481.13
$1.57M
BATE KENNETH
5 Nov 2025
Director
Sold after exercise
1,763
$480.24
$846.66K
Showing 250 of 766 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 247
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 19
Sales on a Rule 10b5-1 plan 87
Sales straight out of an exercise 401
Sales at will 56
Transactions with no price 0
Shares from compensation/vesting 8,643,657
Sales filed before the plan box existed 18
History held since 24 Oct 2016